Related Experiment Video
Updated: Jan 13, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Parkinson's Disease and Frailty: A Two-Way Link Across Aging
Daniel Hernández-Triana1, Salomón Páez-García1, Alexandre Mena2
1Semillero de Neurociencias y Envejecimiento, Pontificia Universidad Javeriana, Bogotá 110231, Colombia.
Abstract:
Background: Parkinson's disease (PD) and frailty frequently co-occur and may interact bidirectionally through shared mechanisms of aging biology, mitochondrial dysfunction, inflammation, and reduced physiological reserve. Objective: We aimed to synthesize current evidence on prevalence, directionality, clinical overlap, adverse outcomes, and management implications of the PD-frailty nexus. Methods: A narrative review of epidemiologic, cohort, and interventional studies was performed, examining frailty in PD and PD risk in prefrail/frail populations, plus trials of multimodal interventions. Results: Frailty is common in PD, affecting approximately one-third of patients overall and becoming more prevalent as the disease advances. It independently predicts falls, cognitive decline, hospitalization, institutionalization, and mortality. Large cohorts suggest prefrailty/frailty is associated with incident PD risk, supporting a potential bidirectional association rather than direct causation. Diagnostic complexity arises because PD motor and non-motor features overlap with frailty constructs, risking misclassification. Management based on Comprehensive Geriatric Assessment (CGA) enhances personalized, multidisciplinary care. Exercise, particularly combined aerobic and resistance training reduces frailty and improves mobility, postural control, and quality of life. Complementary nutritional strategies, including muscle-targeted supplementation, can further strengthen rehabilitation outcomes, while careful attention to social determinants and polypharmacy remains essential to optimizing overall health and functional independence. Conclusions: Frailty is best understood as a clinical marker of vulnerability within PD and a correlate of more adverse trajectories rather than a proven causal determinant. Systematic frailty assessment integrated into PD care may help refine prognosis, individualize treatment, and support efforts to preserve independence. Priorities include PD-adapted frailty tools, CGA implementation, and rigorous trials of combined exercise-nutrition programs.
Related Concept Videos
Parkinson's Disease: Overview
Pharmacodynamics in Geriatric Patients: Effects of Age
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug Dosing: Geriatric Patients

